The QualityStocks Daily Stock List
- MariMed, Inc. (MRMD)
- Aequus Pharmaceuticals, Inc. (AQSZF)
- Cocrystal Pharma, Inc. (COCP)
- Dais Analytic Corp. (DLYT)
- ForeverGreen Worldwide Corporation (FVRG)
- Stealth Technologies, Inc. (STTH)
- A.I.S. Resources Limited (AISSF)
- Elcora Advanced Materials Corp. (ECORF)
- NioCorp Developments Ltd. (NIOBF)
- Uniroyal Global Engineered Products, Inc. (UNIR)
- Wealth Minerals Ltd. (WMLLF)
- Medovex Corporation (MDVX)
- Oculus VisionTech, Inc. (OVTZ)
- Omnitek Engineering Corp. (OMTK)
MariMed, Inc. (MRMD)
Investors Hub, OTC Markets, and DailyMarijuanaObserver reported on MariMed, Inc. (MRMD), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
MariMed, Inc. is an industry leader in the design, development, operation, funding, and optimization of medical cannabis cultivation and production centers and dispensaries. The Company provides turnkey solutions to cannabis cultivators, producers, and dispensaries. It specializes in solutions for securing and operating facilities, manufacturing and processing, dispensary, layouts, and designs, merchandising and sales. OTCQB-listed, MariMed has its corporate office in Newton, Massachusetts.
MariMed is focusing exclusively on serving the fast expanding $7 billion legal cannabis industry. MariMed reported strong revenue growth for 2016 that continued into 2017. The Company more than doubled revenue in 2016 over 2015, increasing from $1.27 million in 2015 to $3.56 million in 2016. Most of the revenue was attributable to subsidiary MariMed Advisors and its cannabis services and products business.
MariMed is on the vanguard of medical research, working to create precision dosed products to treat specific conditions. Its team has developed state-of-the-art and regulatory compliant facilities in numerous states. These facilities are replicable and scalable models of excellence in horticultural principals, cannabis production, product development, as well as dispensary operations.
The Company provides a complete range of consulting services in the medical cannabis industry. It uses a systematic approach, from the permit and application process, to on-time operational readiness. As Cannabis experts, it specializes in supporting the development of high quality state-licensed, medical cannabis dispensaries and cultivation facilities.
MariMed’s services include application assistance, real estate and safe access, build-out and ongoing consultation, business acceleration solutions, and physician and patient outreach. MariMed Advisors, Inc. has a portfolio of high-quality branded products, product development plans, product packaging, and product licensing opportunities.
In November, MariMed announced that it acquired the rights to the intellectual property (IP), formulations, recipes, proprietary equipment, and expertise of Betty’s Eddies from Icky Enterprises LLC. This acquisition enables MariMed to further expand its inventive, industry-leading Kalm Fusion™ precision dosed medical cannabis-infused product line.
Betty’s Eddies is a line of fruit chews handcrafted and naturally sweetened with the finest all natural ingredients and non-GMO organic fruits and vegetables. MariMed has a licensing agreement where Canuvo, Inc., will manufacture and distribute MariMed Kalm Fusion™ and Betty’s Eddies™ branded medical cannabis products in Maine.
Recently, MariMed announced the purchase of a 137,500 sq. ft. industrial building on 17 acres at 167 John Vertente Blvd., in the New Bedford, Massachusetts industrial park for a purchase price of $6,895,000. MariMed will develop roughly 70,000 sq. ft. into a full service state of the art medical cannabis cultivation and production facility. This has been leased to ARL Healthcare, Inc. (ARL), a Massachusetts not for profit corporation.
MariMed assisted ARL Healthcare in its successful application to be awarded a Massachusetts Registered Marijuana Dispensary (RMD) License for cultivation, production, and dispensing of medical cannabis. MariMed will assist ARL Healthcare in the development and ongoing management of the cultivation and manufacturing facility. ARL expects to start cultivation in Q1 of 2018.
MariMed, Inc. (MRMD), closed Thursday's trading session at $3.80, up 3.54%, on 593,789 volume with 922 trades. The average volume for the last 3 months is 415,259 and the stock's 52-week low/high is $0.201/$4.07.
Aequus Pharmaceuticals, Inc. (AQSZF)
StockDailyReview, PennyStockTweets, Investopedia, 4-Traders, OTC Markets, Barchart, Marketwired, InvestorsHub, Stockhouse, and MarketWatch reported on Aequus Pharmaceuticals, Inc. (AQSZF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
A specialty pharmaceutical company, Aequus Pharmaceuticals, Inc.’s focus is on developing, advancing, and promoting differentiated products. The Company’s development stage pipeline includes a number of products in neurology and psychiatry with the aim of addressing the need for improved medication adherence via enhanced delivery systems. OTCQB-listed, Aequus Pharmaceuticals is headquartered in Vancouver, British Columbia.
The Company’s most recent addition to the development pipeline was a long-acting form of medical cannabis. Aequus’ intention is to commercialize its internal programs in Canada together with its present portfolio of marketed established medicines.
Aequus Pharmaceuticals will look to form strategic partnerships, which would maximize the reach of its product candidates globally. Its plan is to build on its Canadian commercial platform via the launch of more products that are either created internally or brought in via an acquisition or license.
Aequus has two preclinical programs now in formulation optimization, AQS-1302 and AQS-1303. AQS-1302 is being advanced for the potential treatment of epilepsy with a once-weekly transdermal application. This is to provide patients with steady-state delivery of their medication. The expectation is that this product will decrease their risk of experiencing breakthrough seizures.
AQS-1303 is in development for the management of Nausea and Vomiting of Pregnancy (NVP). The expectation is that it will provide consistent anti-emetic control. This is while eliminating the risk of missed doses because of emesis (vomiting).
Aequus’ partners include Supernus Pharmaceuticals, Inc., Corium International, Inc., and Transdermal Research Pharm Lab. The Company will continue to expand its commercial pipeline with high quality, differentiated products. These include patented products, branded generics, and reformulated novel-delivery products within focused therapeutic areas. Aequus is developing numerous products in neurology and psychiatry. The aim is addressing the need for improved medication adherence by way of enhanced delivery systems.
This past September, Aequus Pharmaceuticals announced positive results from an initial Proof of Concept clinical study for its long-acting transdermal anti-nausea patch, AQS1303, containing the combination of pyridoxine hydrochloride and doxylamine succinate (the active ingredients in Diclegis®/Diclectin®).
The single-dose cross-over comparative bioavailability study in comparison to the presently approved oral version, Diclegis®/Diclectin®, was successfully completed in nine healthy female volunteers. The results suggested that sustained delivery of therapeutic levels of the active ingredients via the skin over a multi-day period is possible with the present formulation. The formulation was well tolerated. No serious adverse events were reported.
Last month, Aequus Pharmaceuticals announced that the European Patent Office issued an intention to grant a European patent for AQS1301, Aequus' once-weekly transdermal patch containing aripiprazole. AQS1301 is in development for the treatment of certain psychiatric disorders.
The intention of AQS1301 is to provide patients with a long-acting dosing alternative, which is comfortable, convenient, and user-friendly in an effort to promote medication adherence. This is the eighth regional patent issued or granted for AQS1301, following the U.S., Russia, Mexico, Japan, China, Canada, and Australia.
Moreover, Aequus Pharmaceuticals continues to increase revenues from its Canadian commercial arm via the on-going promotion of Vistitan™ and Tacrolimus IR. Vistitan™ (bimatoprost 0.03%) is a treatment for the lessening of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
Tacrolimus IR is the first to market, and currently the only available generic version of tacrolimus immediate release in Canada. This is a product used for the treatment and prevention of acute rejection following organ transplantation.
Aequus Pharmaceuticals, Inc. (AQSZF), closed Thursday's trading session at $0.143, up 7.84%, on 10,988 volume with 9 trades. The average volume for the last 3 months is 21,161 and the stock's 52-week low/high is $0.1155/$0.356.
Cocrystal Pharma, Inc. (COCP)
Microcapmillionaires, Promotion Stock Secrets, Wall Street Resources, and PennyStocks Forever reported on Cocrystal Pharma, Inc. (COCP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Cocrystal Pharma, Inc. develops novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The Company employs innovative technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The design of these technologies, including its nucleoside chemistry expertise and market-centered approach to drug discovery, are to efficiently deliver small molecule therapeutics that are safe, effective, and convenient to administer. Cocrystal Pharma has offices in Tucker, Georgia and Bothell, Washington.
A biotechnology enterprise, the Company’s proprietary technologies revolve around a structure-based drug discovery strategy teamed up with wide-ranging nucleoside experience. Using techniques called protein cocrystallization and X-ray crystallography, Cocrystal Pharma quickly identifies novel binding sites, identifies critical inhibitor-protein interactions, and optimizes the structure of the inhibitor in a highly rapid iterative fashion.
Cocrystal Pharma has identified promising, preclinical stage antiviral compounds for unmet medical needs. These include hepatitis, influenza, and norovirus infections.
The Company is developing a series of compounds that are potent non-nucleoside and nucleoside inhibitors of hepatitis C NS5B RNA dependent RNA polymerase, a replication enzyme crucial to viral replication and are highly conserved between all hepatitis C genotypes. As a result, inhibitors of this enzyme are likely to have multi- or pan-genotypic activity.
Cocrystal Pharma is also developing compounds that inhibit hepatitis C helicase and NS5A, two enzymes important for viral replication. The Company also has identified a picomolar inhibitor of NS5A; another important viral replication protein. Its compounds that target NS5B hepatitis C polymerase, NS5A, and NS3 helicase will undergo development as a combination treatment.
Recently, Cocrystal Pharma announced that its Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) is now open. Cocrystal Pharma is cleared to start its Phase 2a clinical study evaluating CC-31244 for the treatment of hepatitis C virus (HCV) infected individuals.
The Phase 2a study is an open-label study. The design of it is to evaluate the safety, tolerability and preliminary efficacy of CC-31244 with approved HCV drugs. Endpoints of the Phase 2a study include changes in HCV RNA viral load, adverse events and laboratory abnormalities. The Company expects to begin its Phase 2a study of CC-31244 in Q2 of 2018 and announce data in Q4 of 2018.
For Q1 2018, Cocrystal Pharma reported a Net Loss of roughly $1,553,000 versus a Net Loss of roughly $2,548,000 for the same period in 2017. As of March 31, 2018, the Company had $1.2 million in cash and cash equivalents.
Cocrystal Pharma, Inc. (COCP), closed Thursday's trading session at $2.44, up 5.63%, on 29,119 volume with 90 trades. The average volume for the last 3 months is 38,356 and the stock's 52-week low/high is $1.61/$8.70.
Dais Analytic Corp. (DLYT)
HotOTC, SmallCapVoice, CoolPennyStocks, MadPennyStocks, StockEgg, StockRich, Stockpalooza, Money Morning, Penny Stock Rumble, FeedBlitz, M2 Communications, SmallCap Pulse, BullRally, PennyInvest, PennyStockVille, and Greenbackers reported earlier on Dais Analytic Corp. (DLYT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Dais Analytic Corp sells its industry-changing nanomaterial technology into the global water, air, and energy markets. A commercial nanotechnology materials enterprise, the Company provides nanotechnology-based applications for heating & cooling, water treatment, and energy storage. It is commercializing its unique Aqualyte™ family of nano-structured materials and processes centering on disruptive air, energy, and water applications. Dais Analytic is headquartered in Odessa, Florida.
The uses of the Aqualyte™ family of nano-structured materials and processes include ConsERV™. This is a commercially available engineered energy recovery ventilator (a heating, ventilation, and air conditioning (HVAC) product).
In addition, the uses include NanoAir™. This is an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle. Uses also include NanoClear™. This is an early beta-stage method for treating contaminated water to provide 1,000 times cleaner potable water.
The NanoClear™ process has consistently shown that Dais Analytic’s novel Aqualyte® material can separate most contaminants from water, realizing almost 'parts per billion' clean product water with little or no fouling of the vital membrane component.
NanoClear™ is a leading-edege water cleaning architecture enabled by the features in the Company’s nanomaterial - Aqualyte™. The NanoClear™ product line is a critical application in purifying contaminated water having high salt content, low pH, or where the requirement for Total Dissolved Solid (TDS) in the product water is 10 or less.
Furthermore uses include NanoCAP™. Dais indicates that NanoCAP™ holds promise to use the Aqualyte™ family to form a disruptive, non-chemical, energy-storage device (an ultra-capacitor) when completed for use in transportation, renewable energy, and also 'smart grid' configurations.
This past summer, Dais Analytic announced it signed a 7 year, non-exclusive agreement with the Menred Group, Zhejiang province, China, to provide its Aqualyte moisture transfer nanomaterial for use in a newer line of Menred energy recovery ventilators (ERV) to sell into the increasing Chinese heating, ventilation and air conditioning (HVAC) market.
Energy Recovery Ventilators are used in association with HVAC equipment to save capital and operating costs. This is while improving the quality of life for the building's occupants.
High effectiveness ERVs, such as ConsERV™ or Menred Group's new line of ERVs to be built utilizing Dais Analytic's Aqualyte nanomaterial, enable architects and engineers to design buildings with considerable volumes of filtered, preconditioned supply air.
Mr. Brian Johnson Dais Analytic’s Chief Technology Officer, said in July 2017, "Dais' ConsERV™ has long been a leader in this field as established by our Air-Conditioning, Heating and Refrigeration Institute (AHRI) certified performance -- along with other similar ratings from 3rd party rating company's worldwide. Our Aqualyte™ nanomaterial, now in its 4th generation, drives this performance and we are excited about working with Menred to bring a new series of ERVs with Aqualyte to the growing Chinese ERV market."
Dais Analytic Corp. (DLYT), closed Thursday's trading session at $0.04, up 2.56%, on 22,375 volume with 2 trades. The average volume for the last 3 months is 68,315 and the stock's 52-week low/high is $0.0099/$0.0875.
ForeverGreen Worldwide Corporation (FVRG)
Stockhouse, Investopedia, OTC Markets, InvestorsHub, Investors Hangout, and Stock Orange reported on ForeverGreen Worldwide Corporation (FVRG), and we also report on the Company, here at the QualityStocks Daily Newsletter.
ForeverGreen Worldwide Corporation is an international direct marketing company and provider of health and wellness products. The Company develops, manufactures, and distributes an extensive line of all-natural whole foods and products to North America, Australia, Europe, Asia, and South America.
ForeverGreen Worldwide is headquartered in Lindon, Utah. The Company was established in May of 2004 by Chief Executive Officer and Chairman Mr. Ron Williams. ForeverGreen Worldwide lists on the OTC Markets Group’s OTCQB.
The Company’s products include its new global Xpress offering Prodigy-5™, featuring the exclusive TransArmor™ Nutrient Technology. In addition, its products include PowerStrips™, SolarStrips™, with industry exclusive marine phytoplankton and BeautyStrips™.
ForeverGreen Worldwide also offers the North American market its weight-management line called Ketopia™, as well as additional weight management products. Furthermore, the Company offers its Pulse-8™ powered L-arginine formula for cardiovascular health.
ForeverGreen Worldwide announced earlier this year its new wearable technology called CareWear™. The presale of this device, with continuous monitoring from the health application GoHeart, was a limited time offer with a first-time association of use with the Company's nutrition products.
CareWear, in combination with daily use of ForeverGreen nutritional products, is what ForeverGreen Worldwide is positioning as the Total Health Experience, which completes the outside edge of nature, science, products, education and technology formulated in research and development (R&D) of all ForeverGreen’s product offerings.
This past September, ForeverGreen Worldwide announced that Dr. Balamurali Ambati, Ph.D., M.D., and Dr. Adam Saucedo, M.D., were training ForeverGreen Members with a series of presentations in multiple languages. The purpose of the recorded webinar series was to continue ForeverGreen’s streamlined approach of positioning products and to educate Members regarding TransArmor™ Nutrient Technology developed by the doctors, to increase brand awareness, and subsequent Member enrolment.
TransAmor™ Nutrient Technology is patent pending. It was created from four decades of peer-reviewed science. It allows the nutrients in formulated products to be considerably better absorbed by the body.
ForeverGreen Worldwide’s Prodigy-5 is an all-in-one nutritional shot. It features the patent-pending and exclusive TransArmor™ Nutrient Technology for increased absorption. Prodigy-5 provides vitamins, minerals, antioxidants and energy, all in one.
ForeverGreen Worldwide Corporation (FVRG), closed Thursday's trading session at $0.239, up 13.81%, on 32,075 volume with 7 trades. The average volume for the last 3 months is 19,145 and the stock's 52-week low/high is $0.025/$0.389.
Stealth Technologies, Inc. (STTH)
NetworkNewsWire and RedChip reported previously on Stealth Technologies, Inc. (STTH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Stealth Technologies, Inc. is a technology business listed on the OTC Markets Group’s OTCQB. The Company previously went by the name Excelsis Investments, Inc. It changed its name to Stealth Technologies, Inc. in July 2016. Stealth Technologies engages in identifying and capitalizing on technology and associated markets. The Company produces products for personal and financial protection.
Incorporated in 2010, Stealth Technologies has its corporate office in Largo, Florida. It became public through a reverse merger in 2012.
Moreover, Stealth Technologies announced in March of this year the completion of five new products. Currently, these products are staged in a large direct response retailer's quality assurance and legal department. They are under final review to ensure that marketing claims associated with each product are accurate when measured against actual performance levels of each product, and that assurance and inventory is satisfactory and has met all quality control factors. Stealth Technologies’ strategic initiative is to expand its product footprint across varied industries and distributors.
The Company has developed a group of products to protect against "electronic pickpockets," emergency response latency, credit fraud protection, and cell phone data protection. Its initial product to market is the Stealth Card.
The design of the Stealth Card is to protect the Radio-Frequency Identification (RFID) chip in a consumer's credit card from electronic stealing or pickpocketing, which uses a smartphone, credit card reader, or RFID antenna to remotely access data stored on the consumer's Smartchip. Stealth Card renders the chipped information invisible to intrusion.
The Stealth Card is a 100 percent USA product. The Stealth Card is manufactured from Stealth Technologies’ laboratory and research/development facility in West Virginia to its manufacturing facility in Massachusetts.
Development for the Stealth Card started in 2012. This is when Company Founder and Chief Executive Officer (CEO), President, and Director, Mr. Brian McFadden, observed the worldwide shift towards smart chip card technology to transmit and process credit card/debit card transactions. With Europe and Asia already making the transition away from the magnetic strip to smart chip cards, Mr. McFadden believed the United States market would need to follow suit.
To use the Stealth Card, a person places a Stealth Card in their wallet, pocket, change purse or anywhere they carry their credit cards. One card can protect up to 12 cards in a wallet. The card can be physically placed anywhere in a wallet or pocket.
The card does not need to be in the front or back of one’s wallet. The Stealth Card provides effective protection irrespective of where it’s placed in relation to one’s credit cards.
In December 2016, Stealth Technologies announced the development of the 911 Help Now Generation II Product. The 911 Help Now product provides a direct two-way voice connection to emergency service providers. The 911 Help Now pendent works by pressing the Help Now button and then a person is connected.
Stealth Technologies has a number of other products under development. The Company is exploring potential military applications of its proprietary technologies.
Along with the Stealth Card and the 911 Help Now Generation II Product, Stealth Technologies’ portfolio includes Data Secure Plus, which is new to market. Its portfolio also includes Stealth Mobile.
Stealth Technologies, Inc. (STTH), closed Thursday's trading session at $0.022, up 2.33%, on 3,630 volume with 1 trade. The average volume for the last 3 months is 2,573 and the stock's 52-week low/high is $0.013/$0.60.
A.I.S. Resources Limited (AISSF)
Wall Street Analyzer, Stockhouse, Barchart, Business Insider, The Street, YCharts, Morningstar, MarketWatch, InvestorsHub, GuruFocus, Stockwatch, and Penny Stock Hub reported on A.I.S. Resources Limited (AISSF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, A.I.S. Resources Limited established in 1967. The Company is managed by experienced, highly qualified professionals who have a long record of accomplishment of success in lithium exploration, production and capital markets. They identify and develop early stage projects globally that have strong potential for growth. A.I.S. Resources has its head office in Nassau, Bahamas. The Company also has a Canadian office in Vancouver, British Columbia.
A.I.S. Resources concentrates on developing significant lithium resource projects in Argentina’s world-renowned Lithium Triangle. The Company has two large projects, Chiron and Guayatayoc. The Chiron Project is 2,732 Ha. The Guayatayoc Project is 5,225 Ha. A.I.S. Resources also has its Vilama Project in the Lithium Triangle. Vilama is 2,500 Ha.
Guayatayoc is an approved borate mine. It encompasses all industrial minerals including lithium. Guayatayoc and Guayatayoc III are in Jujuy Province, 5 kilometers from the town of Abralaite in the Puna plateau. This property encompasses about 5,000 hectares of the Guayatayoc Salar that hosts favorable geology for lithium and boron, positioned adjacent to the El Aguillar mountain range, the source of lithium and boron.
The Chiron Project comprises four concessions in the Salar de Quirón in the Province of Salta, roughly 10 kilometers from the township of Pocitos. Very encouraging results from other, close by, explorers classifies the Chiron Project as having considerable prospectivity.
Recently, A.I.S. Resources Limited announced it was granted an exploration license for seismic and drilling at its Chiron project. This allows A.I.S to quickly progress to a TEM seismic program and then drilling immediately thereafter.
The Company entered into a contract with Quantec Geoscience Argentina S.A. to conduct a 19 point TEM (VES) seismic survey in early January 2018. This work will be completed by February 2018. Preliminary tenders have been received from several drilling companies for an eight hole program of 3,200 meters.
Last week, A.I.S. Resources announced that seismic testing detected three distinct aquifers over a wide-ranging region at its Chiron Project in the Pocitos Salar, Salta Province, Argentina.
Mr. Phil Thomas, A.I.S. Resources’ Chief Operating Officer and Exploration Director stated: "This initial seismic data from Chiron based on the TEM geophysics strongly supports our case for acquiring these strategic concessions. Together with our Guayatayoc Project to the northwest in Jujuy province, where we've made excellent progress with our pilot plant production chemistry, A.I.S. is on track for a breakthrough year as an emerging new producer in the lithium brine space in Argentina."
A.I.S. Resources Limited (AISSF), closed Thursday's trading session at $0.0904, up 5.48%, on 17,750 volume with 5 trades. The average volume for the last 3 months is 35,055 and the stock's 52-week low/high is $0.0794/$1.22.
Elcora Advanced Materials Corp. (ECORF)
InvestorIntel reported previously on Elcora Advanced Materials Corp. (ECORF), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Elcora Advanced Materials Corp. has been designed to become a vertically integrated (from mine to product) graphite & graphene company, which mines, processes, refines graphite, and produces the graphene and end user graphene applications. The Company has developed a unique low cost-effective process to make high quality graphite and graphene that are commercially scalable. Elcora Advanced Materials is based in Bedford, Nova Scotia. The Company lists on the OTC Markets’ OTCQB.
Elcora Advanced Materials is targeting high-end graphite applications (Li-ion batteries, graphene production & coating). It acquired the full operational control and a 40 percent equity interest in Sakura Graphite (PVT) Limited, operators of the Ragedara mine in Sri Lanka. Sri Lanka graphite is very high quality with many unique properties. This graphite is suitable for use in numerous high-end graphite applications.
Elcora has secured high-grade graphite and graphene precursor graphite from its interest in the operation of the Ragedara mine in Sri Lanka. This mine is already in production. Currently, the mine yields about 500 tonnes each year.
The Company developed its own unique graphite refining process. The process does not require the use of acids or alkaline systems. Environmentally friendly, the process yields higher quality graphite that has not been oxidized and will withstand high temperatures.
Elcora announced in April 2017 that it is building a state-of-the-art Lithium Ion (Li-ion) battery research and development laboratory in Halifax, Nova Scotia. The lab will concentrate on quality control and developing the Company’s graphite anode powder for Li-ion batteries.
Graphite powder will be routinely tested employing industry standard cells. This is to ensure the coulombic efficiency, reversible capacity, first-cycle loss and rate capabilities of the product are within Elcora’s specifications.
Last month, Elcora Advanced Materials announced that it is working with a number of battery manufacturers in Asia that are testing the Company’s graphite anode powder. Elcora has so far sent more than14 kgs of its EL-I-C6 graphite anode powder to battery manufacturers to test its electrochemical performance.
The purpose of this testing is to demonstrate that the Company’s EL-I-C6 graphite anode powder meets Li-ion battery manufacturing standards. After more testing, Elcora Advanced Materials hopes to enter into negotiations for long-term supply agreements.
Moreover, in November, Elcora announced it signed a Memorandum of Understanding (MOU) agreement with Lockheed Martin Canada. This represents Lockheed Martin's first battery technology investment in Canada.
The strategic partnership supports the increasing energy demand for Lithium-Ion battery storage solutions applied to commercial, industrial, utility, and military applications. The MOU formally creates a working relationship and guidelines to support/identify opportunities within Lockheed Martin business units; including Lockheed’s energy division to help in maximizing and attaining sales goals.
Elcora Advanced Materials Corp. (ECORF), closed Thursday's trading session at $0.1476, up 9.33%, on 6,128 volume with 4 trades. The average volume for the last 3 months is 14,464 and the stock's 52-week low/high is $0.115/$0.439.
NioCorp Developments Ltd. (NIOBF)
Proactive Investors, Equity Clock, Savvy Trader Resource, InvestorsHub, Stockhouse, StreetInsider, Morningstar, MarketWatch, 4-Traders, InvestorIntel, Junior Mining Network, and Simply Wall St reported on NioCorp Developments Ltd. (NIOBF), and we also report on the Company, here at the QualityStocks Daily Newsletter.
NioCorp Developments Ltd. is a developer of superalloy metals. The Company is developing a superalloy materials project in Southeast Nebraska. This Project will produce Niobium, Scandium, as well as Titanium. The company previously went by the name Quantum Rare Earth Developments Corp. It changed its name to NioCorp Developments Ltd. in March of 2013. The Company has its corporate office in Centennial, Colorado.
NioCorp Developments is developing North America's only niobium/scandium/ titanium project. The Elk Creek Project is the highest grade niobium project in North America, and the largest prospective producer of scandium globally. The Elk Creek Project is situated near Elk Creek, Nebraska.
Niobium is used to produce superalloys and High Strength, Low Alloy steel. Scandium is a superalloy material, which can be combined with Aluminum to make alloys with increased strength and improved corrosion resistance. Titanium is used in different superalloys.
The Elk Creek Feasibility Study (FS) shows anticipated production of 7,055 tonnes per annum (tpa) of Ferroniobium, 103 tpa of Scandium Trioxide, and 11,445 tpa of Titanium Dioxide over its 32-year operating life.
The estimation is that the Elk Creek Project will have pre-tax Net Present Value (NPV) of US$2.3 billion, with a pre-tax Internal Rate of Return (IRR) of 24.3 percent, and to generate gross Life Of Mine (LOM) revenue of $17.6 billion, with operating margin of $12.2 billion. The economics were calculated using an 8 percent discount rate.
The Trump Administration will officially designate as “Critical Minerals” the entire planned product suite of superalloy metals, which NioCorp proposes to mine and process at its Elk Creek, Nebraska Superalloy Materials project.
The designation establishes the Elk Creek Project as one of the few polymetallic greenfield mining projects in the United States that proposes to produce manifold Critical Minerals – Niobium, Scandium, and Titanium, in this case – which all have vital uses in national defense and civilian technologies and upon which the United States is presently 100 percent dependent on foreign nations including China and Russia.
Today, NioCorp Developments announced that it awarded a major contract to Rockwell Automation (ROK) to engineer, design, and procure process automation and instrumentation for NioCorp’s proposed critical minerals, mining and processing facility in Elk Creek, Nebraska.
Mr. Mark Smith, Executive Chairman and Chief Executive Officer of NioCorp Developments, said, “We selected Rockwell Automation and its partners to automate our process equipment and power control systems with the goals of optimizing material handling and processing, increasing efficiencies and reducing time to market. Their combination of industry expertise, proven methodologies and advanced automation technology should help us develop a truly world-class mine that can initiate the first-ever greenfield mining and processing of niobium and scandium in the United States.”
NioCorp Developments Ltd. (NIOBF), closed Thursday's trading session at $0.49, up 16.67%, on 278,439 volume with 70 trades. The average volume for the last 3 months is 110,637 and the stock's 52-week low/high is $0.293/$0.62.
Uniroyal Global Engineered Products, Inc. (UNIR)
Zacks, MarketWatch, and Marketbeat.com reported on Uniroyal Global Engineered Products, Inc. (UNIR), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Uniroyal Global Engineered Products, Inc., by way of its subsidiaries, is a foremost manufacturer of vinyl coated fabrics. These fabrics are durable, stain resistant, cost-effective alternatives to leather, cloth, and other synthetic fabric coverings. Formed in 1992, Uniroyal Global Engineered Products (UNIR) is based in Sarasota, Florida. The Company’s shares trade on the OTCQB.
UNIR is a top supplier of vinyl coated fabric materials for the automotive and commercial industries. The Company’s products in the automotive industry are used largely in seating, door panels, head and arm rests, security shades, and trim components.
UNIR’s non-automotive applications include outdoor seating for utility and sports vehicles, and sheeting used in medical, nuclear protection, personal protection, moisture barriers, pool liners, pram and nursery, movie screen, and decorative surface applications.
The Company’s chief brand names include Naugahyde®, BeautyGard®, Flameblocker™, and Spirit Millennium®. In addition, they include Ambla®, Amblon®, Velbex®, Cirroflex®, Plastolene® and Vynide®.
The Company’s 2016 revenue was derived 65 percent from the automotive industry and about 35 percent from the recreational, industrial, indoor and outdoor furnishings, hospitality, and health care markets.
In 2016, UNIR’s Naugahyde brand introduced Casablanca. This is a linen-textured vinyl-coated fabric. Casablanca combines the look and feel of linen with the performance of Naugahyde®.
All of Casablanca’s patterns are flame retardant, stain resistant, as well as anti-microbial. Casablanca features Naugahyde’s exclusive Advanced BeautyGard® top coat finish. This collection was developed with hospitality, contract, marine, and healthcare markets in mind.
In November, Uniroyal Global Engineered Products reported its financial results for Q3 ended October 1, 2017.
Mr. Howard R. Curd, Chairman and Chief Executive Officer of UNIR, said, “Overall, this was a very tough quarter from a sales perspective. The reported decline in Net Sales is isolated to our North American operations as we continue to see gains in our European operations. The North American operations struggled with sharply lower volume, particularly in the automotive sector as volume expectations from certain platforms were not achieved. US consumer preferences are switching to light trucks, SUVs and crossovers which are not significant drivers of our revenue. As a result, many of the US automotive manufacturers idled production lines or entire assembly plants for multiple weeks to reduce inventories. We have taken corrective action to “right size” the costs associated with the lower volumes as well as eliminate certain administrative expenses.”
The Company reported net sales of $22,498,456 and a net loss available to common shareholders of $477,553 or a loss of $0.03 per diluted share for Q3.
Uniroyal Global Engineered Products, Inc. (UNIR), closed Thursday's trading session at $1.55, up 32.48%, on 1,200 volume with 5 trades. The average volume for the last 3 months is 945 and the stock's 52-week low/high is $1.00/$2.50.
Wealth Minerals Ltd. (WMLLF)
TradingView, MarketWatch, and InvestorsHub reported on Wealth Minerals Ltd. (WMLLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Wealth Minerals Ltd. is a mineral resource company headquartered in Vancouver, British Columbia. It has interests in Canada, Mexico, Peru and Chile. The Company’s main emphasis is the acquisition of Lithium projects in South America. This includes interests in the Maricunga Salar in Chile. To date, Wealth Minerals has positioned itself to develop the Aguas Calientes Norte, Pujsa and Quisquiro Salars in Chile (the Trinity Project), and to work alongside existing producers in the prolific Atacama Salar. Wealth Minerals’ shares trade on the OTCQB.
The Company also maintains a portfolio of precious and base metal exploration-stage projects. This portfolio includes the 100 percent Wealth Minerals-owned Coronado property in southern Chihuahua, Mexico that spans 9911 Ha. The portfolio also includes Yanamina (Peru) and Valsequillo (Mexico).
Wealth Minerals announced in November 2016 that its wholly-owned Chilean subsidiary (Wealth Chile) entered into a formal option agreement with Atacama Lithium SpA, where it has been given the exclusive right and option to acquire a 100 percent royalty-free interest in 144 exploration concessions referred to as the Proyecto Atacama Lithium project in the Atacama Salar in Region II of Antofagasta, northern Chile.
The Company’s Wealth Chile entered into a Letter of Intent (LOI) dated December 12, 2016 with arm’s length vendors. As a result, it was given the exclusive right and option to acquire a 100 percent royalty-free interest in the mining concessions referred to as the Laguna Verde project. The Project consists of 23 Concessions for a total of 2,438 hectares. It is in Region III (Atacama), northern Chile.
The Company earlier signed a Letter of Intent (LOI) with Atacama Lithium Chile SpA concerning the grant of an option to acquire additional exploration mining concessions with an aggregate area of roughly 6,300 hectares surrounding the Laguna Verde Project and consisting of the Salar Green and Union projects.
Wealth Minerals also executed a binding letter agreement, where it or a Chilean subsidiary of Wealth was granted the option and right to acquire 49 percent of the issued and outstanding shares of San Antonio Sociedad Contractual Minera and a 24.5 percent beneficial interest in certain exploration and exploitation mining concessions, which comprise the Salares 7 Lithium project (the Seven Salars Project). The Property is a lithium brine asset portfolio currently owned 50 percent by Talison Lithium Ltd. and 50 percent by San Antonio. It has a total area of 39,400 hectares located over seven salars in Region II, northern Chile.
Earlier this month, Wealth Minerals reported that it began drilling at the Laguna Verde lithium project. Drilling at Laguna Verde is part of a more wide-ranging evaluation program that is continuing at the Laguna Verde, Atacama and Trinity projects.
The Company earlier completed Transient Electromagnetic (TEM) and Gravity surveys at Laguna Verde, the results of which were positive. This prompted Wealth Minerals to acquire the additional 6,300 hectares of property at Laguna Verde for a total of 8,700 hectares.
Wealth Minerals also reported this month that it received positive results from geophysical surveys at the Atacama project. Magneto-Telluric (MT) and coincident loop TEM surveys identified very highly conductive zones. These are interpreted to represent porous media with high-salinity fluids (potentially lithium-bearing brines) at depth.
The results provide Wealth Minerals with near-surface and deeper drill targets. Initial drill testing of shallow targets is planned for Q1 2018.
Wealth Minerals Ltd. (WMLLF), closed Thursday's trading session at $0.4648, up 1.04%, on 74,321 volume with 27 trades. The average volume for the last 3 months is 129,764 and the stock's 52-week low/high is $0.41/$1.845. is $0.78/$10.80.
Medovex Corporation (MDVX)
StockTwits reported on Medovex Corporation (MDVX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Medovex Corporation is the developer of the DenerveX® System. This is a new and novel device designed for enduring relief of Facet Joint Syndrome (FJS) related to chronic back pain, a non-addictive, non-opioid drug alternative capable of restoring a patient to a more normal and active lifestyle. The Company established to acquire and develop a diversified portfolio of potentially pioneering medical technology products. OTCQB-listed, Medovex is based in Atlanta, Georgia.
Facet Joint Syndrome (FJS) is also known as spinal osteoarthritis, spinal arthritis, or facet joint osteoarthritis. FJS is a significant health and economic problem in the U.S. and other countries in the EU and Rest of World affecting millions annually. Present treatment options are generally temporary. There is no proven long-lasting option for FJS.
The healthcare executives at Medovex have a proven record of accomplishment of building successful medical device and biotechnology companies. The Company’s DenerveX System is CE Marked in Europe. In addition, it is commercially available in Europe and certain other worldwide markets.
The DenerveX System is a highly differentiated technology. It denervates and removes capsular tissue from the Facet Joint in one single procedure. Treatment results from the combined effect of a deburring or polishing action and RF ablation treatment on the Facet Joint.
Employing this new technique, the slowly rotating burr removes the targeted facet joint synovial membrane and joint surface. This is while the heat ablation destroys tissue and denudes any residual nervous and synovial membrane overlying the joint, removing the end point sensory tissue of the joint.
In November, Medovex announced that it submitted an Investigational Device Exemption (IDE) with the U.S. Food and Drug Administration (FDA) for its DenerveX System targeting pain associated with the Facet Joint. The submission of the IDE marks a significant milestone for the Company.
This past September, Medovex announced that it launched its DenerveX System Device in Spain with leading distributor Prim SA. In October, Medovex announced that it launched its DenerveX System Device in Switzerland with distributor Spine Surgical. Switzerland is one of the most important locations for the worldwide medical technology industry.
Through combining first-class research facilities and highly-developed healthcare systems, Switzerland presents itself as a very attractive location for research, development and production for the medical technology sector.
The DenerveX System consists of the DenerveX Kit, which contains the DenerveX Device, a single use medical device and the DenerveX Pro-40 Power Generator. The DenerveX system is not yet FDA cleared.
Medovex Corporation (MDVX), closed Thursday's trading session at $0.40, up 8.11%, on 10,210 volume with 5 trades. The average volume for the last 3 months is 19,668 and the stock's 52-week low/high is $0.275/$1.21.
Oculus VisionTech, Inc. (OVTZ)
UltimatePennyStock and Profit Status reported earlier on Oculus VisionTech, Inc. (OVTZ), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Oculus VisionTech, Inc. creates systems for document and multimedia protection to fight tampering and digital piracy. The Company designs and markets, to business customers, streaming video content distribution, and Internet Cloud-based digital document protection, based on embedded digital watermarking, and Video-on Demand (VOD) systems, services, and source-to-destination digital media delivery solutions that permit live or recorded digitized and compressed video to be transmitted via the Internet, intranet, satellite, or wireless connectivity.
Oculus VisionTech is based in Vancouver, British Columbia and the Company lists on the OTCQB. The Company previously went by the name USA Video Interactive Corp. It changed its name to Oculus VisionTech, Inc. in January of 2012.
Oculus VisionTech’s Document Watermarking Protection technology will be provided as a Cloud service – Cloud DPS. Cloud DPS provides three document services from the Cloud. One is Protection - accept any incoming document, watermark and return the watermarked document as an encrypted image-based PDF document. The second is Authenticate - validate the authenticity of the protected documents. The third is Storage - storage of the master protected document in digital.
The Company’s systems, services, and delivery solutions include document, still image and motion video digital watermark solutions and documents, photographs (still image) and video content protection. Oculus' technology includes Cloud-DPS. At present, it is promoting the imaged-based Document Protection System (DPS) and developing manifold other products. Before the DPS, Oculus created proprietary technology called Smart Marks, which created imperceptible watermarks for videos.
The Company has developed its first proprietary document viewer application (the Document Viewer) for its DPS technology. This is an important addition to the online digital document protection set it has been developing.
The present version of the Document Viewer is for the Windows operating system. Additionally, Oculus is continuing to develop applications for Mac, iOS, and Android operating systems.
Fundamentally, the Cloud DPS is a system made to protect and authenticate digital documents from tampering. Cloud DPS is meant for documents at the end of the editing cycle.
Furthermore, Cloud DPS creates Visible Watermarks (QR Codes). The core technology in the DPS is the Anti-Tampering Technology.
The construction of the Cloud DPS system is on two chief processes, protection and authentication. Protection changes documents into image based files, which include multiple levels of security. This includes encryption, edit-locking, watermarking, and a state-of-the-art onboard master copy system. Authentication is the process of checking the in document master copy to determine the authenticity of a document.
Oculus VisionTech, Inc. (OVTZ), closed Thursday's trading session at $0.07722, up 6.42%, on 171,334 volume with 36 trades. The average volume for the last 3 months is 46,048 and the stock's 52-week low/high is $0.054/$0.1225.
Omnitek Engineering Corp. (OMTK)
Marketbeat.com, FeedBlitz, OTCPicks, and Penny Stock Rumble reported previously on Omnitek Engineering Corp. (OMTK), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Omnitek Engineering Corp. develops and sells proprietary diesel-to-natural gas conversion systems and complementary products. This includes new natural gas engines that use Omnitek’s technology. These provide its global customers with inventive alternative energy and emissions control solutions that are sustainable and affordable. Omnitek Engineering is headquartered in Vista, California.
The Company’s products include New Natural Gas Engines, Engine Specific Diesel-to-Natural Gas (DNG) Engine Conversion Kits, and products for Diesel-to-Natural Gas Engine Conversions, Engine Management System (EMS) and Components, EFI for V-Twin Motorcycles and Small Engines, and Hydrogen Internal Combustion Engines. The DNG system has established Omnitek Engineering as a leader in the industry.
Omnitek’s conversion technology provides fleets with a 100 percent dedicated natural gas engine at a fraction of the cost of a new natural gas engine. Omnitek Engineering’s commitment is to be at the forefront of technology. Furthermore, the Company’s commitment is to develop innovative solutions that redefine the future of low emissions, energy independence, and transportation.
The Company has established a strategic alliance with LKQ Corp. to produce "drop-in" natural gas engines at Omnitek Engineering’s facility in Monterrey, Mexico, initially for the widely-used Mercedes OM904 and OM906 engines. LKQ is a foremost provider of alternative and specialty parts to repair and accessorize automobiles and other vehicles.
Omnitek Engineering has received worldwide certification for its patented fuel rail technology. This is based on tests conducted by an independent agency and standards sanctioned by the United Nations Economic Commission for Europe, specifically UN ECE R110.
Omnitek will participate in a $1.5 million grant study with its partner Olson-Ecologic Testing Laboratories (Fullerton, California). The study is to demonstrate its clean natural gas engine technology for off-road heavy duty construction vehicle applications in the greater Los Angeles, California area.
Omnitek will develop an 18-liter Caterpillar natural gas engine capable of operating on CNG, LNG, or low-carbon intensive renewable biogas (R-CNG) through using its patented diesel-to-natural gas engine conversion technology. Olson-Ecologic Engine Testing Laboratories will serve as project manager.
This month, Omnitek Engineering announced that it received a contract to develop a heavy-duty 12-liter propane engine for Class 8 trucks and certify the engine to EURO 6 emissions standards. The 12-liter 360 hp propane (LPG) engine complements Omnitek’s current development of a 13-liter 450 hp heavy-duty natural gas engine for Class 8 truck applications to meet EURO 6 emissions.
Omnitek Engineering Corp. (OMTK), closed Thursday's trading session at $0.2055, up 2.75%, on 450 volume with 3 trades. The average volume for the last 3 months is 33,273 and the stock's 52-week low/high is $0.055/$0.469.
The QualityStocks Company Corner
- Earth Science Tech, Inc. (ETST)
- The Flowr Corporation (TSXV: FLWR)
- Youngevity International, Inc. (NASDAQ: YGYI)
- Cyberfort Software, Inc. (CYBF)
- NUGL Inc. (NUGL)
- Sunniva Inc. (CSE: SNN) (OTC: SNNVF)
- Marijuana Company of America Inc. (MCOA)
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)
- Cannabis Strategic Ventures, Inc. (NUGS)
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)
- Sugarmade, Inc. (SGMD)
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)
- Canopy Rivers Inc. (TSX.V:RIV)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, has received updated coverage from SeeThruEquity, which recognizes the Company’s sales growth, recent activity, and market potential. View the full SeeThruEquity report here: view report. Also today, the company was highlighted in an article explaining how the cannabis market continues to emerge as a powerhouse, realizing extreme positive market volume as well as high rates of investment from multiple interests while momentum continues to build on a seemingly daily basis.
Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.
Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
- Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
- Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
- KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.
In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.
The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.
Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.
Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.
The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.
Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.
Earth Science Tech, Inc. (ETST), closed the day's trading session at $1.39, up 27.99%, on 1,075,102 volume with 1,103 trades. The average volume for the last 3 months is 25,679 and the stock's 52-week low/high is $0.393/$1.62.
- Earth Science Tech, Inc. (ETST) Receives Updated Coverage and $3.60 Price Target from SeeThruEquity
- Cannabis Market Heating Up As Consumer Demand Rises Along With Revenue Generating Opportunity
- SeeThruEquity Issues Update on Earth Science Tech, Inc. (OTCQB: ETST)
The Flowr Corporation (TSX.V: FLWR)
The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation.
Steve Klein, chairman of The Flowr Corporation (TSXV: FLWR), was featured in a recent interview published by CFN Media Group. Host Greg Hasty was on location at the Cannabrunch in New York City to speak with industry leaders and high net worth investors in the cannabis space. To view the full press release, visit: http://nnw.fm/r22Yr.
The Flowr Corporation (TSX.V: FLWR), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.
Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.
Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.
Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.
In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.
Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.
Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:
- FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
- Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
- Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.
Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.
Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.
The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $7.00, up 13.64%, on 535,153 volume with 1,009 trades. The stock's 52-week low/high is $4.00/$8.00.
- NetworkNewsBreaks – The Flowr Corporation (TSXV: FLWR) Chairman Featured in Interview by CFN Media Group
- NetworkNewsBreaks – The Flowr Corporation (TSXV: FLWR) Commences Trade on the Toronto Stock Exchange
- QualityStocksNewsBreaks – The Flowr Corp. and The Needle Capital Corp. Successfully Complete Qualifying Transaction
Youngevity International, Inc. (NASDAQ: YGYI)
CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Youngevity International, Inc. (NASDAQ: YGYI), a client of CNW and a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that combines e-commerce and the power of social selling. To view the full publication, titled “CBD Supplements Primed to Explode Ahead of Biopharma as Farm Bill Legalizes Hemp,” visit: http://cnw.fm/iR532.
Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.
Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.
Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.
Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.
Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:
- Health and Nutrition
- Home and Family
- Food and Beverage
- Spa and Beauty
- Essential Oils
- Photo and scrapbooking
- Services for Home and Business
Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.
Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.
Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $6.70, up 8.06%, on 512,659 volume with 1,782 trades. The average volume for the last 3 months is 38,539 and the stock's 52-week low/high is $3.17/$6.59.
- CannabisNewsWire Announces Stage Set for CBD-Based Product Explosion Pending Legalization of Hemp
- CBD Supplements Primed to Explode Ahead of Biopharma as Farm Bill Legalizes Hemp
- Youngevity International, Inc. (NASDAQ: YGYI) 420 with CNW – Utah Set to Vote on Legalization of Medical Cannabis
Cyberfort Software, Inc. (CYBF)
Cyberfort Software (OTC: CYBF), a San Francisco, California-based cybersecurity technology company, specializes in the acquisition and development of cyber security, content filtering and ad blocking technology. To view the full article, visit: http://nnw.fm/29Fu4.
Cyberfort Software, Inc. (CYBF) is a cybersecurity technology company specializing in the acquisition and development of security software, content filtering, and ad blocking technology. Headquartered in San Francisco, California, Cyberfort Software is actively dealing with various cyber threats through the development of innovative protection technologies designed for mobile, personal and business tech devices across multiple platforms.
Committed to the idea that everyone – from individuals to global corporations – should be able to enjoy a digital future free of malicious attacks robbing them of privacy and security, Cyberfort is working to strengthen its portfolio of cybersecurity IPs and stay one step ahead of cyberthreats. The growing plethora of tech devices enveloping everyday life opens the door to increasing cyberattacks through a stunning array of sophisticated cyberthreats. Protecting organizations and individuals with proactive security postures and protective measures is a key component of Cyberfort’s strategy to develop cybersecurity solutions that are smart, simple and efficient.
The company’s 2016 purchase of Vivio, a provider of pioneering AI content filtering and software protection, underscores Cyberfort’s commitment to cybersecurity. Vivio, an iOS 10 ad blocking app, currently serves over 10,000 unique users across iPhone, iPad and Mac. Vivio makes web browsing better, faster and more satisfying by blocking ads and reducing data usage, which also helps save battery life. Continuous ad blocking rule updates are delivered via an Intellectual Property Cloud-based autonomous engine with ad blocking tracker and malware detection filters.
Cyberfort recently signed a letter of intent to acquire Just Content Software which includes the Just Content app, software and underlying source code. Just Content is an efficacious and multi-functional ad blocking app that safeguards families and businesses with proprietary “Home Safe Filter” and “Business Filter” products. The Just Content app is available on iTunes and protects against unsafe links, adult content, phishing sites and inflammatory hate speech found on the internet, among other potential backdoor attacks and cyberthreats. A due diligence review is underway and a final determination regarding this acquisition is anticipated within weeks.
“Cyberfort aims to become a leader in developing cutting edge ad-blocking protective software that keeps the internet safe for families and business, which in our highly technological and immediate information-access society is a significant concern. Acquiring Just Content furthers our commitment to provide the best and most effective ad-blocking software in the marketplace,” says Cyberfort CEO Daniel Cattlin.
Favorable government regulations promoting tightened web security is a major factor driving adoption of web content filtering solution along with the public’s growing desire to better manage network bandwidth consumption and protect their online security and privacy. Cyberfort’s objective is to protect the data and integrity of personal and business computing assets and defend those assets against any threat or attack. The company’s software also offers symbiotic ad-blocking capabilities to complement its cyber defense effectiveness.
As Cyberfort continues to innovate, the Vivio team intends to leverage the current user base as a sandbox to test and optimize future incremental developments targeting an enterprise suite of tools that can be integrated into sector specific areas of growth. Key areas of focus include mobile device management, bring your own device (“BYOD”), mobile app management and secure mobile browser.
The Cyberfort leadership team is headlined by Cattlin, who offers a new age perspective to the business with expertise in project and asset management and a background in corporate finance. Cattlin brings both the operational and financial understanding to take companies from start-up and early development to expansion and capital growth within a public environment.
Chief Technology Officer Tomas Mistrik helped his team deliver a variety of technological products including the Vivio ad-blocking app for iOS 10 and the Silicon Valley-based Synergykit platform for mobile developers.
Technology Development Manager Krishna Kumar brings more than 10 years of experience in the Information Technology industry where he provided powerful security and ad-blocking measures for companies such as CSC and PayPal India.
Senior Advisor Harish Doddala brings nine years of product management and software engineering experience, delivering results for Cisco, VMware, Oracle, IBM and Siemens.
Cyberfort Software, Inc. (OTC: CYBF), closed the day's trading session at $0.13, up 8.70%, on 12,679 volume with 8 trades. The average volume for the last 3 months is 36,920 and the stock's 52-week low/high is $0.0509/$69.00.
- NetworkNewsBreaks – Cyberfort Software, Inc. (CYBF) Envisions Bright Future for Cybersecurity
- Cyberfort Software, Inc. (CYBF) Innovating with Cyber Security
- Cyberfort Software, Inc. (CYBF) in the Process of Acquiring Content Blocking App ‘Just Content’
NUGL Inc. (NUGL)
There’s a good chance that, very soon, someone who wants information on cannabis commerce will “NUG-L” with an application developed by NUGL Inc. (OTC: NUGL), in much the same way that they “Google” a topic.
NUGL Inc. (NUGL) is focused on leading the evolution in business relations, development and organic data in the cannabis industry with a distinct platform. In this effort, it has developed a leading-edge, first of its kind search app and online directory for the marijuana industry that provides a one-stop source and listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.
Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.
“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”
NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.
“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”
NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.
“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”
NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.
CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.
Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-looking software for various industries.
NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.
Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.
NUGL Inc. (NUGL), closed the day's trading session at $2.15, up 10.26%, on 165,659 volume with 223 trades. The average volume for the last 3 months is 163,838 and the stock's 52-week low/high is $0.405/$2.05.
- Could NUGL Inc. (NUGL) Become the Google of Cannabis?
- NUGL Taps Cannabis Industry Leader as VP of Sales, Increases Ad Revenue Options
- NUGL Inc. is on The Forefront of the Cannabis Industry and Tells Uptick Newswire Stock Day Podcast It Only Gets Better from Here
Sunniva, Inc. (CSE: SNN) (OTC: SNNVF)
Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a vertically-integrated medical cannabis provider, aims to raise C$20 million through the sale of units of the company to a syndicate of underwriters spearheaded by Beacon Securities Limited and Canaccord Genuity Corp., according to a company press release (http://nnw.fm/q1sZw).
Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.
The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.
Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.
The Sunniva Family includes:
CP Logistics, LLC
Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.
Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.
These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.
Sunniva Medical Inc.
Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.
Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.
Natural Health Services Ltd.
Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.
In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.
Full-Scale Distributors, LLC
Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.
Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.
Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.
Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.
Sunniva, Inc. (SNNVF), closed the day's trading session at $4.40, off by 0.25%, on 78,129 volume with 121 trades. The average volume for the last 3 months is 70,142 and the stock's 52-week low/high is $3.61/$16.00.
- Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) to Raise C$20 Million through Unit Sale
- Sunniva Inc. Announces Increase to Previously Announced Bought Deal Public Offering
- Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Releases Q2 2018 Results
Marijuana Company of America Inc. (OTC: MCOA)
CannabisNewsAudio announces the Audio Press Release (APR) titled "Something for Everyone: Baby Boomers Signify Shift in the Cannabis Market," featuring Marijuana Company of America Inc. (OTC Pink: MCOA). To hear the CannabisNewsAudio version, visit: http://cnw.fm/4vpBn. To read the full editorial, visit: http://cnw.fm/7G3nB.
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0264, even for the day, on 5,753,719 volume with 297 trades. The average volume for the last 3 months is 7,878,968 and the stock's 52-week low/high is $0.022/$0.073.
- CannabisNewsAudio Announces Audio Press Release (APR) on Marijuana Company of America Inc. Catering to Boomers with Range of Products for Varied Needs
- CannabisNewsWire Announces Baby Boomers Represent Natural Market in Budding Cannabis Industry
- Something for Everyone: Baby Boomers Signify Shift in the Cannabis Market
Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)
Petroteq Energy Inc. (TSXV:PQE; OTC:PQEFF; FSE:PQCF), a fully integrated oil and gas company, is pleased to announce that it has initiated commercial production at its Vernal, Utah facility and publishes the following statement from its CEO, Mr. David Sealock. Also today, the company was highlighted by 24/7 Market News.
Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.
Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.
PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.
“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.
In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.
Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.
The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.
The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.
The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.
The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.
Petroteq Energy Inc. (PQEFF), closed the day's trading session at $0.993, up 0.51%, on 404,048 volume with 258 trades. The average volume for the last 3 months is 405,417 and the stock's 52-week low/high is $0.289/$1.889.
- Petroteq Reaches Commercial Production Milestone and Publishes Statement From the CEO
- Venture Breakfast Bits, by 24/7 Market News
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Maintains Focus on Becoming First Environmentally Friendly Oil Sands Mining Facility
Cannabis Strategic Ventures, Inc. (NUGS)
Cannabis Strategic Ventures, Inc. (OTC Pink: NUGS) is pleased to announce the completion of a full audit for its fiscal year ending March 31, 2018. This completes the three-year audit required as part of becoming a fully reporting company with the U.S. Securities & Exchange Commission (“SEC”). Also today, the company was highlighted by 24/7 Market News.
Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.
The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.
Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.
Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.
Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.
Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.
Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.
The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.
Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $3.97, off by 1.98%, on 56,790 volume with 133 trades. The average volume for the last 3 months is 100,971 and the stock's 52-week low/high is $0.031/$7.13.
- Cannabis Strategic Ventures Announces Completion of Fiscal Year 2018 Audit and Pursues Fully Reporting Status
- Venture Breakfast Bits, by 24/7 Market News
- Inaugural Cannabis Strategic Ventures, Inc. (NUGS) and True Promise Beauty CBD-Based Product Line Set to Be Launched by Year-End 2018
Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)
ParcelPal Technology Inc. ("ParcelPal" or the "Company"), (CSE: PKG) (FSE: PT0) (OTC: PTNYF) - is pleased to announce they have signed an agreement for Cannabis distribution with Vancouver, BC based Choom Holdings, Inc. (CSE:C HOO) (OTC: CHOOF) Canada's leading cannabis retailer.
Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.
Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.
True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.
Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.
A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.
While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.
Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.87, off by 3.33%, on 259,526 volume with 327 trades. The average volume for the last 3 months is 293,393 and the stock's 52-week low/high is $0.18/$1.13.
- ParcelPal Signs Agreement for Marijuana Distribution With Choom Holdings Inc.
- Canadian Cannabis Upcoming Legalization Expected to Transform the Legal Marijuana Industry Across North America
- Choom™ Announces Inclusion to the Horizons Marijuana Life Sciences ETF
Sugarmade, Inc. (SGMD)
CannabisNewsAudio announces the Audio Press Release (APR) titled "Hydroponic Hardware Key to Tapping Long-Term Profits of Burgeoning Cannabis Market," featuring Sugarmade, Inc. (OTC Pink: SGMD). To hear the CannabisNewsAudio version, visit: http://cnw.fm/gStR5. To read the full editorial, visit: http://cnw.fm/VraZ0.
Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.
Sugarmade, Inc. (SGMD), closed the day's trading session at $0.0894, off by 2.83%, on 1,779,540 volume with 187 trades. The average volume for the last 3 months is 1,564,756 and the stock's 52-week low/high is $0.028/$0.43.
- CannabisNewsAudio Announces Audio Press Release (APR) on Sugarmade, Inc. Exploiting "Picks and Shovels" Approach to Budding Cannabis Sector
- CannabisNewsWire Announces Cannabis Demand for Controlled Production Triggers Boon to Hydroponics Industry
- Hydroponic Hardware Key to Tapping Long-Term Profits of Burgeoning Cannabis Market
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)
VIVO Cannabis Inc. (TSX-V: VIVO; OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that is has qualified to trade on the OTCQX® Best Market. VIVO upgraded to OTCQX from the OTCQB® Venture Market.
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.
“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.
VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.
VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.
This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.
VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.
VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.
Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.
With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.
VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $1.1483, off by 7.40%, on 522,111 volume with 592 trades. The average volume for the last 3 months is 691,418 and the stock's 52-week low/high is $0.73/$3.29.
- VIVO Cannabis Inc. Upgrades to the OTCQX Best Market
- VIVO Completes First New Seasonal Greenhouse
- 420 with CNW – Michigan Judge Halts Cannabis Business Closures
Canopy Rivers Inc. (TSX.V: RIV)
Canopy Rivers Inc. (TSX.V:RIV) parent, Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), today responded to Ontario's retail rollout plan. The Company is looking forward to serving customers at retail locations at the site of its production facilities and especially looks forward to initiating the process of obtaining the necessary retail licences required to operate cannabis retail at its Smiths Falls headquarters where a merchandise store is already in place at a Tweed-branded visitor centre.
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.
Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.
Canopy Rivers’ expanding portfolio includes:
- Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
- CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
- Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
- James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
- LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
- PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
- Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
- Solo Growth (TSXV:ALZ) is a premiere retail cannabis distributor that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Canada’s largest private liquor retailer, Solo Liquor, who collectively have more than 50 years of regulated substance retail experience. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy as “Solo Growth Corp.”
- Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
- TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
- Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.
As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.
Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.
Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $6.31, off by 8.55%, on 1,137,379 volume with 2,617 trades. The stock's 52-week low/high is $3.188/$11.82.
- Canopy Growth Provides Comments on Ontario Retail, BC Production, First Recreational Shipments
- NetworkNewsBreaks – Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) Applauds Canopy Rivers Inc.’s (TSXV: RIV) Commencement of Trading on the TSX Venture Exchange
- Will Canopy Growth’s Spin-Off Canopy Rivers Be A Powerful Growth Engine?
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a report from CannabisNewsWire explaining how a recent study which was published in the Journal of American Medical Association (JAMA) Pediatrics Edition has revealed that almost one in 11 American teenagers uses an electronic cigarette to consume cannabis. Also today, the company announced that Cam Battley has resigned from the Board of Directors.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at email@example.com
The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $5.34, off by 7.93%, on 1,380,292 volume with 3,526 trades. The average volume for the last 3 months is 816,053 and the stock's 52-week low/high is $2.784/$7.89.
- 420 with CNW – Nearly 1 in 11 Teens Vapes Marijuana
- The Green Organic Dutchman Announces Board Resignation
- The Green Organic Dutchman Provides Update on Spin-off Transaction and Announces Intention of TGOD Acquisition to Complete Private Placement Offering of Subscription Receipts
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- 665 Energy (SSOF) Sixty Six Oilfield Services, Inc. Announces Name Change to 665 Energy, Engages NetworkNewsWire for Investor Relations, Proceeds With Audit
- Accelerated Technologies Holding Corp. (ATHC) Receives Positive Feedback from Intelagy Launch
- Aftermaster, Inc. (AFTM) to Host Shareholder Update Call on August 21, 2018
- American Helium (TSX.V: AHE) (OTC: AHELF) Provides Shareholder Update
- Auscrete Corp. (ASCK) CEO, John Sprovieri, and Mr. Spiro Sapounas Discuss Recent News and More in an Exclusive Audio Interview at SmallCapVoice.com
- BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Product Responsive to Concerns about Cannabis Lab Testing Quality
- BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Announces Positive Phase IIa Proof of Concept Data in Advanced Breast Cancer; Initiates Combination Study
- Cannabis Strategic Ventures, Inc. (NUGS) Announces Completion of Fiscal Year 2018 Audit and Pursues Fully Reporting Status
- Canopy Rivers Inc.’s (TSXV: RIV) Canopy Growth Provides Comments on Ontario Retail, BC Production, First Recreational Shipments
- ChineseInvestors.com (CIIX) to Present at the MicroCap Conference in New York City on October 1st
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) ParcelPal Signs Agreement for Marijuana Distribution
- Consorteum Holdings, Inc. (CSRH) Focusing on Mobile Initiatives
- Cyberfort Software, Inc. (CYBF) Envisions Bright Future for Cybersecurity
- CytoDyn Inc. (CYDY) to Acquire Biotech Developing Therapies to Stop Cancer from Spreading
- DeepMarkit Inc. (TSX.V: MKT) (OTC: MKTDF) “Gamify” Platform Proves its Worth with Positive Feedback
- DPW Holdings, Inc. (NYSE American: DPW) SpyGlass Hill Capital Lending Corp. Announces Launch of MonthlyInterest.com Internet Investment Portal
- Earth Science Tech, Inc. (ETST) Receives Updated Coverage and $3.60 Price Target from
- FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) Investee Company Receives First Purchase Order
- First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF) Auto Industry Entrepreneur and Design Icon Henrik Fisker Joins First Cobalt Board of Directors
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Secures Additional Sale of QuadSight™ Prototype
- Global Payout, Inc. (GOHE) MGR2, LLC Makes Strides to Include MTrac Payment Platform in Legislation Across the Nation
- Golden Developing Solutions, Inc. (DVLP) 420 with CNW – Michigan Judge Halts Cannabis Business Closures
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – Massachusetts Credit Union to Offer Banking Services to Cannabis Industry
- GreenBox POS, LLC (GRBX) Centers on Blockchain-Secured Ledger Technology
- GTX Corp (GTXO) Norwegian Government Awards GTX Corp Distributor a Two Year contract to Supply GPS Tracking Devices
- Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) New Merger Agreement with Canopy Growth and Potential Synergies
- Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) Announces Release Schedule for World's First Cannabis Infused Nootropic Beverage
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Innovative Platform Demonstrates Excellent Results in Delivery of APIs to the Brain
- Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) First Assay Results from Lithium Drill Project Increase Potential
- Marifil Mines Ltd.’s (TSX.V: MFM) (OTC: MFMLF) Preliminary Assay Results from Four Drill Holes at San Roque Property Show Mineralization
- Marijuana Company of America Inc. (MCOA) CannabisNewsAudio Announces Audio Press Release (APR) on Marijuana Company of America Inc. Catering to Boomers with Range of Products for Varied Needs
- Medical Cannabis Payment Solutions (REFG) Provides Banking Solution for State-Sanctioned Medical Marijuana Establishments
- Net Element, Inc. (NASDAQ: NETE) Market Trends Toward New Normal in Eros International, Federated Investors, Oaktree Capital Group, Civeo, Potbelly, and Net Element — Emerging Consolidated Expectations, Analyst Ratings
- NUGL Inc. (NUGL) Become the Google of Cannabis?
- Pacific Software, Inc. (PFSF) 420 with CNW – Nearly 1 in 11 Teens Vapes Marijuana
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Reaches Commercial Production Milestone and Publishes Statement From the CEO
- Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) Launches Mass Market Hemp-Infused Beverages and Supplements
- Pressure BioSciences Inc. (PBIO) Launches HUB880 Explorer; First Instrument Sold to Leading Japanese Research Institute
- PreveCeutical Medical Inc. (CSE: PREV) (OTC: PRVCF) (FSE: 18H) Enters into Development Agreement with Asterion Cannabis Inc. to Develop Medicinal Cannabinoid Products
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Expands Lithium Property as Lithium Demand Continues to Rise
- Sharing Services, Inc. (SHRV) Approved for Trading on the OTCQB Venture Market
- SinglePoint, Inc. (SING) Launches Powerful ‘SingleCoin’ Crypto Wallet, Puts Users in Control
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) is “One to Watch”
- Sugarmade, Inc. (SGMD) CannabisNewsAudio Announces Audio Press Release (APR) on Sugarmade, Inc. Exploiting "Picks and Shovels" Approach to Budding Cannabis Sector
- Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) to Raise C$20 Million through Unit Sale
- Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology - QualityStocksNewsBreaks
- The Flowr Corp. (TSX.V: FLWR) Chairman Featured in Interview by CFN Media Group
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) 420 with CNW – Nearly 1 in 11 Teens Vapes Marijuana
- TMSR Holding Company Ltd. (NASDAQ: TMSR) is a Recognized Leader in China’s $16B Solid Waste Recycling Industry
- TransCanna™ Set to Get Marijuana Moving Across California ‘Pot Desert’ Landscape
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Upgrades to the OTCQX Best Market
- WhereverTV Broadcasting Corp. (TVTV) Answers Growing Demand for Exclusive, Over-the-Top TV Streaming Content
- Youngevity International, Inc. (NASDAQ: YGYI) CannabisNewsWire Announces Stage Set for CBD-Based Product Explosion Pending Legalization of Hemp
- Zenergy Brands, Inc. (ZNGY) Focuses on Efficient Energy Usage Solutions for Its Customers
- Zenosense, Inc. (ZENO) Heart Attack Testing Technology Development Continues to Advance Hopes of Portable Point of Care Device
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.